Categorie > Clinical Trials / Drug Trials

New Alterations Found In Young Adults With Type 2 Diabetes

Categorie : Clinical Trials / Drug Trials
Diet and aerobic exercise are highly effective for the treatment of type 2 diabetes, but not for obese subjects that have developed the disease when very young... ...

read more Diet and aerobic exercise are highly effective for the treatment of type 2 diabetes, but not for obese subjects that have developed the disease when very young... read more Sun Mar 2010

Antibiotic Lessens Symptoms In Movement Disorder

Categorie : Clinical Trials / Drug Trials
Discovery of an antibiotic's capacity to improve cell function in laboratory tests is providing movement disorder researchers with leads to more desirable molecules with potentially similar traits, according to University of Alabama scientists co-authoring a paper publishing March 10 in the journal ...

read more Discovery of an antibiotic's capacity to improve cell function in laboratory tests is providing movement disorder researchers with leads to more desirable molecules with potentially similar traits, according to University of Alabama scientists co-authoring a paper publishing March 10 in the journal read more Sun Mar 2010

Athena Feminine Technologies, Inc. Initiates Enrollment Of Phase Iv Clinical Trial For Athena Pelvic Muscle Trainer™

Categorie : Clinical Trials / Drug Trials
Athena Feminine Technologies, Inc., in partnership with the National Association of Nurse Practitioners in Women's Health, announced the initiation of a nationwide enrollment for Phase IV of the DUETS (Device for Urinary Incontinence, Effectiveness, Tolerability and Satisfaction) research study for ...

read more Athena Feminine Technologies, Inc., in partnership with the National Association of Nurse Practitioners in Women's Health, announced the initiation of a nationwide enrollment for Phase IV of the DUETS (Device for Urinary Incontinence, Effectiveness, Tolerability and Satisfaction) research study for read more Sun Mar 2010

Access Pharmaceuticals Reports Significant Oral Bioavailability Of Cobalamin(TM) Oral Insulin In Additional Studies

Categorie : Clinical Trials / Drug Trials
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted animal studies. The studies, which confirm earlier findings, were performed as part of on-going work with commerci ...

read more ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted animal studies. The studies, which confirm earlier findings, were performed as part of on-going work with commerci read more Sun Mar 2010

Newly-Published Study Reinforces Role Of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) As An Add-on Treatment That Significantly Reduces Epilepsy

Categorie : Clinical Trials / Drug Trials
UCB announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported the app ...

read more UCB announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported the app read more Sun Mar 2010

Study Reinforces Role Of AED Vimpat (Lacosamide) (C-V) As Add-On Treatment For POS

Categorie : Clinical Trials / Drug Trials
UCB has announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported th ...

read more UCB has announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported th read more Sun Mar 2010

The Results Are In: Users Of BodyMedia's Wearable Body-Monitoring Technology Lose 3 Times More Weight

Categorie : Clinical Trials / Drug Trials
With obesity in America reaching alarming levels -- across our adult and youth populations -- results from a clinical trial unveiled by BodyMedia confirm that participants who used BodyMedia's wearable body-monitoring technology either in conjunction with a group weight loss program or as part of th ...

read more With obesity in America reaching alarming levels -- across our adult and youth populations -- results from a clinical trial unveiled by BodyMedia confirm that participants who used BodyMedia's wearable body-monitoring technology either in conjunction with a group weight loss program or as part of th read more Sun Mar 2010

Abbott Seeks FDA Approval Of A New Six-Month 45-mg Formulation Of Lupron(R) Depot For The Palliative Treatment Of Advanced Prostate Cancer

Categorie : Clinical Trials / Drug Trials
The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental new drug application (sNDA) of a new six-month 45-mg formulation of Lupron® Depot (leuprolide acetate for depot suspension) for use in the palliative treatment of advanced prostate cancer. Palliative treatment he ...

read more The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental new drug application (sNDA) of a new six-month 45-mg formulation of Lupron® Depot (leuprolide acetate for depot suspension) for use in the palliative treatment of advanced prostate cancer. Palliative treatment he read more Sun Mar 2010

BioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool

Categorie : Clinical Trials / Drug Trials
bioMerieux a world leader in the field of in vitro diagnostics announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE)... ...

read more bioMerieux a world leader in the field of in vitro diagnostics announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE)... read more Sun Mar 2010

FDA Approves Five-Day Dosing Regimen For Dacogen(R) (decitabine) For Injection, Offering A New Outpatient Dosing Option For Myelodysplastic Syndromes

Categorie : Clinical Trials / Drug Trials
Eisai Inc announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells... ...

read more Eisai Inc announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells... read more Sun Mar 2010

Stimuvax Will Become Decision Resources' Proprietary Clinical Gold Standard For The Treatment Of Locally Advanced Non-Small-Cell Lung Cancer

Categorie : Clinical Trials / Drug Trials
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Merck KGaA/Oncothyreon's Stimuvax vaccine earns Decision Resources' proprietary clinical gold standard status in 2013 and 2018 for the treatment of locally advanced non-sma ...

read more Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Merck KGaA/Oncothyreon's Stimuvax vaccine earns Decision Resources' proprietary clinical gold standard status in 2013 and 2018 for the treatment of locally advanced non-sma read more Sun Mar 2010

Diabetes Experts Call For Early, Integrated Treatment Approach To Help Prevent Complications And Improve Patient Outcomes

Categorie : Clinical Trials / Drug Trials
Results from a new online survey of more than 300 practicing endocrinologists and family medicine physicians1 show that a large majority of physicians (83 percent)1 indicated that using a team of specialists early in the course of type 2 diabetes (T2D) treatment can help prevent serious T2D-related ...

read more Results from a new online survey of more than 300 practicing endocrinologists and family medicine physicians1 show that a large majority of physicians (83 percent)1 indicated that using a team of specialists early in the course of type 2 diabetes (T2D) treatment can help prevent serious T2D-related read more Sun Mar 2010

TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing In Diabetic Foot Infection Met Primary Endpoints

Categorie : Clinical Trials / Drug Trials
TaiGen Biotechnology Co., Ltd. announced the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability. Nemonoxacin is a novel non-fluorinated quinolone that has a broad spe ...

read more TaiGen Biotechnology Co., Ltd. announced the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability. Nemonoxacin is a novel non-fluorinated quinolone that has a broad spe read more Sun Mar 2010

Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine

Categorie : Clinical Trials / Drug Trials
Baxter International Inc. (NYSE:BAX), in conjunction with DynPort Vaccine Company LLC (DVC), a CSC Company (NYSE:CSC), presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter's Vero cell culture pl ...

read more Baxter International Inc. (NYSE:BAX), in conjunction with DynPort Vaccine Company LLC (DVC), a CSC Company (NYSE:CSC), presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter's Vero cell culture pl read more Sun Mar 2010

Treatment Of Portal Hypertensive Pulmonary Lesions Induced By Schistosomiasis

Categorie : Clinical Trials / Drug Trials
To evaluate efficacy of Calculus Bovis compound preparation (ICCBco) in the treatment of lung lesions in portal hypertensive rabbits with schistosomiasis as the experimental animal model, a research group in China performed a randomized, double-blind, controlled trial to observe pathological changes ...

read more To evaluate efficacy of Calculus Bovis compound preparation (ICCBco) in the treatment of lung lesions in portal hypertensive rabbits with schistosomiasis as the experimental animal model, a research group in China performed a randomized, double-blind, controlled trial to observe pathological changes read more Sat Mar 2010

Transcendental Meditation Activates Default Mode Network, The Brain's Natural Ground State

Categorie : Clinical Trials / Drug Trials
A new EEG study conducted on college students at American University found they could more highly activate the default mode network, a suggested natural "ground state" of the brain, during their practice of the Transcendental Meditation technique... ...

read more A new EEG study conducted on college students at American University found they could more highly activate the default mode network, a suggested natural read more Sat Mar 2010

Phase III REGION-I Study Shows PEP005 (ingenol Mebutate) Gel 0.05% May Reduce Pre-Cancerous Skin Lesions In Patients With Actinic Keratosis

Categorie : Clinical Trials / Drug Trials
Specialty pharmaceutical company LEO Pharma announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scien ...

read more Specialty pharmaceutical company LEO Pharma announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scien read more Sat Mar 2010

ISIS Initiates Phase 1 Clinical Trial Of ISIS-SOD1Rx In Patients With ALS

Categorie : Clinical Trials / Drug Trials
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that it has initiated a Phase 1 study of ISIS-SOD1Rx in patients with an inherited, aggressive form of Lou Gehrig's disease also known as familial amyotrophic lateral sclerosis (ALS). Approximately 20 percent of all familial ALS cases are caused b ...

read more Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that it has initiated a Phase 1 study of ISIS-SOD1Rx in patients with an inherited, aggressive form of Lou Gehrig's disease also known as familial amyotrophic lateral sclerosis (ALS). Approximately 20 percent of all familial ALS cases are caused b read more Sat Mar 2010

COPPERTONE(R) Solar Research Center Unveils Studies On Efficacy Of Topical Antioxidants In Sunscreens At 2010 Annual Meeting

Categorie : Clinical Trials / Drug Trials
Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc., the makers of COPPERTONE®, announced at the 2010 Annual Meeting of the American Academy of Dermatology the results of studies demonstrating the efficacy of topical antioxidants in broad spectrum sunscr ...

read more Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc., the makers of COPPERTONE®, announced at the 2010 Annual Meeting of the American Academy of Dermatology the results of studies demonstrating the efficacy of topical antioxidants in broad spectrum sunscr read more Sat Mar 2010

Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study Of Picoplatin In Metastatic Prostate Cancer

Categorie : Clinical Trials / Drug Trials
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castr ...

read more Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castr read more Sat Mar 2010

1 | 2 | 3 | 4 next >>>

eHealth Guide News Abortion ADHD Aid / Disasters Alcohol / Addiction Allergy Alzheimer's Anxiety Arthritis Asthma / Respiratory Autism Bio-terrorism / Terrorism Biology / Biochemistry Bipolar Bird Flu / Avian Flu Blood / Hematology Body Aches Bones / Orthopaedics Breast Cancer Cancer / Oncology Cardiovascular / Cardiology Caregivers / Homecare Cholesterol CJD / vCJD / Mad Cow Disease Cleft Palate Clinical Trials / Drug Trials Colorectal Cancer Complementary Medicine / Alternative Medicine Compliance Conferences Cosmetic Medicine / Plastic Surgery Crohn's Cystic Fibrosis Dentistry Depression Dermatology Diabetes Dyslexia Ear, Nose and Throat Endocrinology Epilepsy Erectile Dysfunction / Premature Ejaculation Eye Health / Optometry Fertility Flu / SARS GastroIntestinal Genetics Gout Headache / Migraine Health Insurance / Medical Insurance Hearing / Deafness HIV / AIDS Huntingtons Disease Hypertension Immune System / Vaccines Infectious Diseases / Bacteria / Viruses Irritable-Bowel Syndrome Liver Disease / Hepatitis Lung Cancer Lupus Lymphoma / Leukemia Medical Devices Medical Malpractice / Litigation Medical Students Medicare / Medicaid / Tricare Men's health Mental Health MRI / PET / Ultrasound MRSA / Drug Resistance Multiple Sclerosis Muscular Dystrophy Neurology / Neuroscience Nursing Nutrition/Agriculture Obesity / Weight Loss / Fitness Pain / Anesthetics Parkinson's Disease Pediatrics Pharma Industry Pregnancy Primary Care / General Practice Prostate Psychology / Psychiatry Public Health Radiology / Nuclear Medicine Rehabilitation Schizophrenia Seniors / Aging Sexual Health / STDs Sleep / Sleep Disorders Smoking / Quit Smoking Sports Medicine / Fitness Statins Stem Cell Research Stroke / Neuroprotection Transplants / Organ Donations Tropical Diseases Urology / Nephrology Veterinary Water Quality / Air Quality Women's Health / OBGYN Health Policy Health Jobs Listing